Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study
Carregando...
Citações na Scopus
105
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
MIELE, L.
PONZIANI, F. R.
TODA, A. K.
Citação
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, v.28, n.4, p.369-384, 2018
Resumo
Background and Aim: The aim of the study was to compare the gut microbiomes from obese and lean patients with or without NASH to outline phenotypic differences. Methods and Results: We performed a cross-sectional pilot study comprising biopsy-proven NASH patients grouped according to BMI. Microbiome DNA was extracted from stool samples, and PCR amplification was performed using primers for the V4 region of the 16S rRNA gene. The amplicons were sequenced using the Ion PGM Torrent platform, and data were analyzed using QIIME software. Macronutrient consumption was analyzed by a 7-day food record. Liver fibrosis >= F2 was associated with increased abundance of Lactobacilli (p = 0.0007). NASH patients showed differences in Faecalibacterium, Ruminococcus, Lactobacillus and Bifidobacterium abundance compared with the control group. Lean NASH patients had a 3-fold lower abundance of Faecalibacterium and Ruminococcus (p = 0.004), obese NASH patients were enriched in Lactobacilli (p = 0.002), and overweight NASH patients had reduced Bifidobacterium (p = 0.018). Moreover, lean NASH patients showed a deficiency in Lactobacillus compared with overweight and obese NASH patients. This group also appeared similar to the control group with regard to gut microbiome alpha diversity. Although there were qualitative differences between lean NASH and overweight/obese NASH, they were not statistically significant (p = 0.618). The study limitations included a small sample size, a food questionnaire that collected only qualitative and semi-quantitative data, and variations in group gender composition that may influence differences in FXR signaling, bile acids metabolism and the composition of gut microbiota. Conclusion: Our preliminary finding of a different pathogenetic process in lean NASH patients needs to be confirmed by larger studies, including those with patient populations stratified by sex and dietary habits.
Palavras-chave
Gut microbiome, NASH, Lean, Obese, Overweight
Referências
- Al-Jashamy K, 2010, ASIAN PAC J CANCER P, V11, P1765
- Baba CS, 2006, J GASTROEN HEPATOL, V21, P191, DOI 10.1111/j.1440-1746.2005.04233.x
- Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158
- Bellentani S, 2008, HEPATOLOGY, V47, P746, DOI 10.1002/hep.22009
- Betrapally NS, 2016, GASTROENTEROLOGY, V150, P1745, DOI 10.1053/j.gastro.2016.02.073
- Boursier J, 2016, CLIN LIVER DIS, V20, P263, DOI 10.1016/j.cld.2015.10.012
- Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356
- Brahe LK, 2013, OBES REV, V14, P950, DOI 10.1111/obr.12068
- Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
- Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
- de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, pG589, DOI 10.1152/ajpgi.00488.2011
- Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI [10.1002/hep.28572/suppinfo, 10.1002/hep.28572]
- Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x
- Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096
- Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132
- Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
- Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85
- Lin H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21618
- Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
- Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe
- Machado MV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040481
- Manti S, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.17641
- Margariti E, 2012, J GASTROENTEROL, V25, P45
- Miquel S, 2015, MBIO, V6, DOI 10.1128/mBio.00300-15
- Mosca A, 2017, J HEPATOL, V66, P1031, DOI 10.1016/j.jhep.2016.12.025
- Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705
- Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193
- Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502
- Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739
- Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
- Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015
- Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789
- Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020
- Scott KP, 2014, FEMS MICROBIOL ECOL, V87, P30, DOI 10.1111/1574-6941.12186
- Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9
- Trottier J, 2011, CLIN PHARMACOL THER, V90, P279, DOI 10.1038/clpt.2011.124
- Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
- Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
- Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
- Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X
- Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986
- Wong VWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062885
- Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093
Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - FM/MFT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - LIM/46
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - FM/MFT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - LIM/46
Artigos e Materiais de Revistas Científicas - ODS/03